Skip to main content

EDITORIAL article

Front. Cardiovasc. Med.
Sec. Heart Failure and Transplantation
Volume 11 - 2024 | doi: 10.3389/fcvm.2024.1421447
This article is part of the Research Topic Infiltrative Cardiomyopathy and Heart Failure View all 6 articles

Editorial: Infiltrative Cardiomyopathy and Heart Failure

Provisionally accepted
Nicole K. Bart Nicole K. Bart 1,2,3,4*Liza Thomas Liza Thomas 3,5,6Diane Fatkin Diane Fatkin 1,2,3
  • 1 St Vincent’s Hospital Sydney, Darlinghurst, Australia
  • 2 Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia
  • 3 University of New South Wales, Kensington, New South Wales, Australia
  • 4 University of Notre Dame, Sydney, Australia
  • 5 Westmead Hospital, Westmead, New South Wales, Australia
  • 6 The University of Sydney, Darlington, New South Wales, Australia

The final, formatted version of the article will be published soon.

    Keywords: Amyloid, Sarcoid, Heart Failure, cardiomyopathy, heart failure with preserved ejection faction

    Received: 22 Apr 2024; Accepted: 01 May 2024.

    Copyright: © 2024 Bart, Thomas and Fatkin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Nicole K. Bart, St Vincent’s Hospital Sydney, Darlinghurst, Australia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.